Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Sinomune Pharmaceutical General Information
Sinomune Pharmaceutical has several approved and late-stage products primarily in dermatology and nephrology. Its lead programs include combination topical therapies for psoriasis and acne vulgaris, as well as iron-based phosphate binders for hyperphosphatemia. The company also develops traditional Chinese medicine-derived products targeting autoimmune diseases. Clinical results support efficacy in their approved indications.
Contact Information
Primary Industry
Biotech
Corporate Office
Wuxi, Jiangsu
China
China
Drug Pipeline
No pipeline data available
Key Partnerships
Aptar Pharma – packaging/device partner for rosacea treatment delivery system
Sinomune Pharmaceutical Funding
No funding data available
To view Sinomune Pharmaceutical's complete valuation and funding history, request access »